Cancer Genetics, Inc. (Nasdaq: CGIX) announces an exclusive distribution agreement that provides Sayre Therapeutics sales and marketing rights of Cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE